Capital Expenditures - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NuVasive Inc
Capital Expenditures Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Capital Expenditures
-$142.8m
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
-13%
Becton Dickinson and Co
NYSE:BDX
Capital Expenditures
-$723m
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
-2%
Boston Scientific Corp
NYSE:BSX
Capital Expenditures
-$791m
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Stryker Corp
NYSE:SYK
Capital Expenditures
-$612m
CAGR 3-Years
-13%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Abbott Laboratories
NYSE:ABT
Capital Expenditures
-$2.2B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Capital Expenditures
-$1.2B
CAGR 3-Years
-68%
CAGR 5-Years
-33%
CAGR 10-Years
-30%

See Also

What is NuVasive Inc's Capital Expenditures?
Capital Expenditures
-142.8m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Capital Expenditures amounts to -142.8m USD.

What is NuVasive Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-13%

Over the last year, the Capital Expenditures growth was -13%. The average annual Capital Expenditures growth rates for NuVasive Inc have been -8% over the past three years , -7% over the past five years , and -13% over the past ten years .

Back to Top